Skip to main content
. 2012 Jul 5;3(3):93–96. doi: 10.4021/wjon506w

Table 1. Metastatic Melanoma Treatments and Effects.

Treatment Partial response (decrease in tumor size by at least 50%) Complete response (no tumor detectable) Overall Response Median Overall Survival Reference
Biochemotherapy vs. Chemotherapy 21% vs. 15% 7% vs. 3.5% 28% vs. 18.5% No difference 2
Interleukin 2 10% 6% 16% 11.4 months 7
Ipilimumab vs. Chemotherapy 13.6% vs. 9.5% 1.6% vs. 0.8% 15.2% vs. 10.3% 11.2 months vs. 9.1 months 20
Vemurafenib vs. Chemotherapy 47% vs. 5% 1% vs. 0% 48% vs. 5% At 6 months: 84% vs. 64% 22